Global In Vitro Cancer Diagnostics (IVD) Market Size, Share, Growth Analysis Report - Forecast 2034
In Vitro Cancer Diagnostics (IVD) Market By Product & Service (Reagents, Instruments, and Software & Services), By Technique (Immunodiagnostics, Hematology, Molecular Diagnostics, Tissue Diagnostics, and Clinical Chemistry), and By Region: Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2025 - 2034
| Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 77.07 Billion | USD 144.96 Billion | 6.5% | 2024 |
Table Of Content
- Chapter 1. Preface
- 1.1. Report Description and Scope
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology
- Chapter 2. Executive Summary
- 2.1. In-Vitro Cancer Diagnostics Market, 2016 - 2026, (USD Million)
- 2.2. In-Vitro Cancer Diagnostics Market: Snapshot
- Chapter 3. Global In-Vitro Cancer Diagnostics Market – Industry Analysis
- 3.1. In-Vitro Cancer Diagnostics Market: Market Dynamics
- 3.2. Market Drivers
- 3.2.1. Rising incidences of chronic lifestyle diseases across the globe
- 3.2.2. Growing aging population, and increasing usage of point-of-care testing and personalized medicine
- 3.3. Restraints
- 3.3.1. Inadequate returning pulicy and stringent regulatory approval framework
- 3.4. Opportunity
- 3.4.1. Ongoing research and development in the healthcare sector coupled with advancement in medical technulogies
- 3.5. Porter’s Five Forces Analysis
- 3.6. Market Attractiveness Analysis
- 3.6.1. Market attractiveness analysis by Product segment
- 3.6.2. Market attractiveness analysis by Technology segment
- 3.6.3. Market attractiveness analysis by Application segment
- 3.6.4. Market attractiveness analysis by regional segment
- Chapter 4. Global In-Vitro Cancer Diagnostics Market - Competitive Landscape
- 4.1. Company market share analysis
- 4.1.1. Global In-Vitro Cancer Diagnostics market: company market share analysis, 2018
- 4.2. Strategic development
- 4.2.1. Acquisitions & mergers
- 4.2.2. New Technology launches
- 4.2.3. Agreements, partnerships, cullaborations and joint ventures
- 4.2.4. Research and development and regional expansion
- 4.1. Company market share analysis
- Chapter 5. Global In-Vitro Cancer Diagnostics Market – product Segment Analysis
- 5.1. Global In-Vitro Cancer Diagnostics market overview: by Product
- 5.1.1. Global In-Vitro Cancer Diagnostics market revenue share, by Product, 2019 and 2026
- 5.2. Instruments
- 5.2.1. Global In-Vitro Cancer Diagnostics market by Instruments, 2016-2026 (USD Million)
- 5.3. Reagents and Kits
- 5.3.1. Global In-Vitro Cancer Diagnostics market by Reagents and Kits, 2016-2026 (USD Million)
- 5.4. Data Management System/Software
- 5.4.1. Global In-Vitro Cancer Diagnostics market by Data Management System/Software, 2016-2026 (USD Million)
- 5.5. Services
- 5.5.1. Global In-Vitro Cancer Diagnostics market by Services, 2016-2026 (USD Million)
- 5.1. Global In-Vitro Cancer Diagnostics market overview: by Product
- Chapter 6. Global In-Vitro Cancer Diagnostics Market – Technology Segment Analysis
- 6.1. Global In-Vitro Cancer Diagnostics market overview: by Technology
- 6.1.1. Global In-Vitro Cancer Diagnostics market revenue share, by Technology, 2019 and 2026
- 6.2. Clinical Chemistry
- 6.2.1. Global In-Vitro Cancer Diagnostics market by Clinical Chemistry, 2016-2026 (USD Million)
- 6.3. Immunochemistry/Immunoassays
- 6.3.1. Global In-Vitro Cancer Diagnostics market by Immunochemistry/Immunoassays, 2016-2026 (USD Million)
- 6.4. Hematulogy
- 6.4.1. Global In-Vitro Cancer Diagnostics market by Hematulogy, 2016-2026 (USD Million)
- 6.5. Coagulation and Hemostasis
- 6.5.1. Global In-Vitro Cancer Diagnostics market by Coagulation and Hemostasis, 2016-2026 (USD Million)
- 6.6. Microbiulogy
- 6.6.1. Global In-Vitro Cancer Diagnostics market by Microbiulogy, 2016-2026 (USD Million)
- 6.7. Molecular Diagnostics
- 6.7.1. Global In-Vitro Cancer Diagnostics market by Molecular Diagnostics, 2016-2026 (USD Million)
- 6.8. Other IVD Technologies
- 6.8.1. Global In-Vitro Cancer Diagnostics market by Other IVD Technologies, 2016-2026 (USD Million)
- 6.1. Global In-Vitro Cancer Diagnostics market overview: by Technology
- Chapter 7. Global In-Vitro Cancer Diagnostics Market – Application Segment Analysis
- 7.1. Global In-Vitro Cancer Diagnostics market overview: by Application
- 7.1.1. Global In-Vitro Cancer Diagnostics market revenue share, by Application, 2019 and 2026
- 7.2. Laboratories
- 7.2.1. Global In-Vitro Cancer Diagnostics market by Laboratories, 2016-2026 (USD Million)
- 7.3. Hospitals
- 7.3.1. Global In-Vitro Cancer Diagnostics market by Hospitals, 2016-2026 (USD Million)
- 7.4. Academic Institutes
- 7.4.1. Global In-Vitro Cancer Diagnostics market by Academic Institutes, 2016-2026 (USD Million)
- 7.5. Point-of-care Testing
- 7.5.1. Global In-Vitro Cancer Diagnostics market by Point-of-care Testing, 2016-2026 (USD Million)
- 7.6. Patient Self-testing
- 7.6.1. Global In-Vitro Cancer Diagnostics market by Patient Self-testing, 2016-2026 (USD Million)
- 7.7. Other End Users
- 7.7.1. Global In-Vitro Cancer Diagnostics market by Other End Users, 2016-2026 (USD Million)
- 7.1. Global In-Vitro Cancer Diagnostics market overview: by Application
- Chapter 8. Global In-Vitro Cancer Diagnostics Market - Regional Analysis
- 8.1. Global In-Vitro Cancer Diagnostics market overview: by region
- 8.1.1. Global In-Vitro Cancer Diagnostics market revenue share, by region, 2019 and 2026
- 8.2. North America
- 8.2.1. North America In-Vitro Cancer Diagnostics market, by country, 2016-2026 (USD Million)
- 8.2.2. North America In-Vitro Cancer Diagnostics market revenue, by Product, 2016-2026 (USD Million)
- 8.2.3. North America In-Vitro Cancer Diagnostics market revenue, by Technology, 2016-2026 (USD Million)
- 8.2.4. North America In-Vitro Cancer Diagnostics market revenue, by Application, 2016-2026 (USD Million)
- 8.2.5. The U.S.
- 8.2.5.1. The U.S. In-Vitro Cancer Diagnostics market revenue, by Product, 2016-2026 (USD Million)
- 8.2.5.2. The U.S. In-Vitro Cancer Diagnostics market revenue, by Technology, 2016-2026 (USD Million)
- 8.2.5.3. The U.S. In-Vitro Cancer Diagnostics market revenue, by Application, 2016-2026 (USD Million)
- 8.2.6. Rest of North America
- 8.2.6.1. Rest of North America In-Vitro Cancer Diagnostics market revenue, by Product, 2016-2026 (USD Million)
- 8.2.6.2. Rest of North America In-Vitro Cancer Diagnostics market revenue, by Technology, 2016-2026 (USD Million)
- 8.2.6.3. Rest of North America In-Vitro Cancer Diagnostics market revenue, by Application, 2016-2026 (USD Million)
- 8.3. Europe
- 8.3.1. Europe In-Vitro Cancer Diagnostics market, by country, 2016-2026 (USD Million)
- 8.3.2. Europe In-Vitro Cancer Diagnostics market revenue, by Product, 2016-2026 (USD Million)
- 8.3.3. Europe In-Vitro Cancer Diagnostics market revenue, by Technology, 2016-2026 (USD Million)
- 8.3.4. Europe In-Vitro Cancer Diagnostics market revenue, by Application, 2016-2026 (USD Million)
- 8.3.5. U.K.
- 8.3.5.1. U.K. In-Vitro Cancer Diagnostics market revenue, by Product, 2016-2026 (USD Million)
- 8.3.5.2. U.K. In-Vitro Cancer Diagnostics market revenue, by Technology, 2016-2026 (USD Million)
- 8.3.5.3. U.K. In-Vitro Cancer Diagnostics market revenue, by Application, 2016-2026 (USD Million)
- 8.3.6. France
- 8.3.6.1. France In-Vitro Cancer Diagnostics market revenue, by Product, 2016-2026 (USD Million)
- 8.3.6.2. France In-Vitro Cancer Diagnostics market revenue, by Technology, 2016-2026 (USD Million)
- 8.3.6.3. France In-Vitro Cancer Diagnostics market revenue, by Application, 2016-2026 (USD Million)
- 8.3.7. Germany
- 8.3.7.1. Germany In-Vitro Cancer Diagnostics market revenue, by Product, 2016-2026 (USD Million)
- 8.3.7.2. Germany In-Vitro Cancer Diagnostics market revenue, by Technology, 2016-2026 (USD Million)
- 8.3.7.3. Germany In-Vitro Cancer Diagnostics market revenue, by Application, 2016-2026 (USD Million)
- 8.3.8. Rest of Europe
- 8.3.8.1. Rest of Europe In-Vitro Cancer Diagnostics market revenue, by Product, 2016-2026 (USD Million)
- 8.3.8.2. Rest of Europe In-Vitro Cancer Diagnostics market revenue, by Technology, 2016-2026 (USD Million)
- 8.3.8.3. Rest of Europe In-Vitro Cancer Diagnostics market revenue, by Application, 2016-2026 (USD Million)
- 8.4. Asia Pacific
- 8.4.1. Asia Pacific In-Vitro Cancer Diagnostics market, by country, 2016-2026 (USD Million)
- 8.4.2. Asia Pacific In-Vitro Cancer Diagnostics market revenue, by Product, 2016-2026 (USD Million)
- 8.4.3. Asia Pacific In-Vitro Cancer Diagnostics market revenue, by Technology, 2016-2026 (USD Million)
- 8.4.4. Asia Pacific In-Vitro Cancer Diagnostics market revenue, by Application, 2016-2026 (USD Million)
- 8.4.5. China
- 8.4.5.1. China In-Vitro Cancer Diagnostics market revenue, by Product, 2016-2026 (USD Million)
- 8.4.5.2. China In-Vitro Cancer Diagnostics market revenue, by Technology, 2016-2026 (USD Million)
- 8.4.5.3. China In-Vitro Cancer Diagnostics market revenue, by Application, 2016-2026 (USD Million)
- 8.4.6. Japan
- 8.4.6.1. Japan In-Vitro Cancer Diagnostics market revenue, by Product, 2016-2026 (USD Million)
- 8.4.6.2. Japan In-Vitro Cancer Diagnostics market revenue, by Technology, 2016-2026 (USD Million)
- 8.4.6.3. Japan In-Vitro Cancer Diagnostics market revenue, by Application, 2016-2026 (USD Million)
- 8.4.7. India
- 8.4.7.1. India In-Vitro Cancer Diagnostics market revenue, by Product, 2016-2026 (USD Million)
- 8.4.7.2. India In-Vitro Cancer Diagnostics market revenue, by Technology, 2016-2026 (USD Million)
- 8.4.7.3. India In-Vitro Cancer Diagnostics market revenue, by Application, 2016-2026 (USD Million)
- 8.4.8. Rest of Asia Pacific
- 8.4.8.1. Rest of Asia Pacific In-Vitro Cancer Diagnostics market revenue, by Product, 2016-2026 (USD Million)
- 8.4.8.2. Rest of Asia Pacific In-Vitro Cancer Diagnostics market revenue, by Technology, 2016-2026 (USD Million)
- 8.4.8.3. Rest of Asia Pacific In-Vitro Cancer Diagnostics market revenue, by Application, 2016-2026 (USD Million)
- 8.5. Latin America
- 8.5.1. Latin America In-Vitro Cancer Diagnostics market, by country, 2016-2026 (USD Million)
- 8.5.2. Latin America In-Vitro Cancer Diagnostics market revenue, by Product, 2016-2026 (USD Million)
- 8.5.3. Latin America In-Vitro Cancer Diagnostics market revenue, by Technology, 2016-2026 (USD Million)
- 8.5.4. Latin America In-Vitro Cancer Diagnostics market revenue, by Application, 2016-2026 (USD Million)
- 8.5.5. Brazil
- 8.5.5.1. Brazil In-Vitro Cancer Diagnostics market revenue, by Product, 2016-2026 (USD Million)
- 8.5.5.2. Brazil In-Vitro Cancer Diagnostics market revenue, by Technology, 2016-2026 (USD Million)
- 8.5.5.3. Brazil In-Vitro Cancer Diagnostics market revenue, by Application, 2016-2026 (USD Million)
- 8.5.6. Rest of Latin America
- 8.5.6.1. Rest of Latin America In-Vitro Cancer Diagnostics market revenue, by Product, 2016-2026 (USD Million)
- 8.5.6.2. Rest of Latin America In-Vitro Cancer Diagnostics market revenue, by Technology, 2016-2026 (USD Million)
- 8.5.6.3. Rest of Latin America In-Vitro Cancer Diagnostics market revenue, by Application, 2016-2026 (USD Million)
- 8.6. Middle East & Africa
- 8.6.1. Middle East & Africa In-Vitro Cancer Diagnostics market, 2016-2026 (USD Million)
- 8.6.2. Middle East & Africa In-Vitro Cancer Diagnostics market revenue, by Product, 2016-2026 (USD Million)
- 8.6.3. Middle East & Africa In-Vitro Cancer Diagnostics market revenue, by Technology, 2016-2026 (USD Million)
- 8.6.4. Middle East & Africa In-Vitro Cancer Diagnostics market revenue, by Application, 2016-2026 (USD Million)
- 8.1. Global In-Vitro Cancer Diagnostics market overview: by region
- Chapter 9. Company Profiles
- 9.1. Roche Diagnostics.
- 9.1.1. Overview
- 9.1.2. Financials
- 9.1.3. Product Portfolio
- 9.1.4. Business Strategy
- 9.1.5. Recent Developments
- 9.2. Abbott Laboratories
- 9.2.1. Overview
- 9.2.2. Financials
- 9.2.3. Product Portfolio
- 9.2.4. Business Strategy
- 9.2.5. Recent Developments
- 9.3. Becton, Dickson and Company
- 9.3.1. Overview
- 9.3.2. Financials
- 9.3.3. Product Portfolio
- 9.3.4. Business Strategy
- 9.3.5. Recent Developments
- 9.4. Ortho-Clinical Diagnostics
- 9.4.1. Overview
- 9.4.2. Financials
- 9.4.3. Product Portfolio
- 9.4.4. Business Strategy
- 9.4.5. Recent Developments
- 9.5. Johnson and Johnson
- 9.5.1. Overview
- 9.5.2. Financials
- 9.5.3. Product Portfolio
- 9.5.4. Business Strategy
- 9.5.5. Recent Developments
- 9.6. Danaher Corporation
- 9.6.1. Overview
- 9.6.2. Financials
- 9.6.3. Product Portfolio
- 9.6.4. Business Strategy
- 9.6.5. Recent Developments
- 9.7. Thermo Fisher Scientific
- 9.7.1. Overview
- 9.7.2. Financials
- 9.7.3. Product Portfolio
- 9.7.4. Business Strategy
- 9.7.5. Recent Developments
- 9.8. Siemens Healthcare
- 9.8.1. Overview
- 9.8.2. Financials
- 9.8.3. Product Portfolio
- 9.8.4. Business Strategy
- 9.8.5. Recent Developments
- 9.9. Bio-Rad Laboratories, Inc
- 9.9.1. Overview
- 9.9.2. Financials
- 9.9.3. Product Portfolio
- 9.9.4. Business Strategy
- 9.9.5. Recent Developments
- 9.10. Sysmex Corporation
- 9.10.1. Overview
- 9.10.2. Financials
- 9.10.3. Product Portfolio
- 9.10.4. Business Strategy
- 9.10.5. Recent Developments
- 9.1. Roche Diagnostics.
Table Of Figures
List of Figures
1. Market research process
2. Market research methodology
3. Global In-Vitro Cancer Diagnostics market, 2016-2026 (USD Million)
4. Porter’s five forces analysis: In-Vitro Cancer Diagnostics market
5. Global In-Vitro Cancer Diagnostics market attractiveness, by Product
6. Global In-Vitro Cancer Diagnostics market attractiveness, by Technology
7. Global In-Vitro Cancer Diagnostics market attractiveness, by Application
8. Global In-Vitro Cancer Diagnostics market revenue share, by Product, 2019 and 2026
9. Global In-Vitro Cancer Diagnostics market by Instruments, 2016-2026 (USD Million)
10. Global In-Vitro Cancer Diagnostics market by Reagents and Kits, 2016-2026 (USD Million)
11. Global In-Vitro Cancer Diagnostics market by Data Management System/Software, 2016-2026 (USD Million)
12. Global In-Vitro Cancer Diagnostics market by Services, 2016-2026 (USD Million)
13. Global In-Vitro Cancer Diagnostics market revenue share, by Technology, 2019 and 2026
14. Global In-Vitro Cancer Diagnostics market by Clinical Chemistry, 2016-2026 (USD Million)
15. Global In-Vitro Cancer Diagnostics market by Immunochemistry/Immunoassays, 2016-2026 (USD Million)
16. Global In-Vitro Cancer Diagnostics market by Hematology, 2016-2026 (USD Million)
17. Global In-Vitro Cancer Diagnostics market by Coagulation and Hemostasis, 2016-2026 (USD Million)
18. Global In-Vitro Cancer Diagnostics market by Microbiology, 2016-2026 (USD Million)
19. Global In-Vitro Cancer Diagnostics market by Molecular Diagnostics, 2016-2026 (USD Million)
20. Global In-Vitro Cancer Diagnostics market by Other IVD Technologies, 2016-2026 (USD Million)
21. Global In-Vitro Cancer Diagnostics market revenue share, by Application, 2019 and 2026
22. Global In-Vitro Cancer Diagnostics market by Laboratories, 2016-2026 (USD Million)
23. Global In-Vitro Cancer Diagnostics market by Hospitals, 2016-2026 (USD Million)
24. Global In-Vitro Cancer Diagnostics market by Academic Institutes, 2016-2026 (USD Million)
25. Global In-Vitro Cancer Diagnostics market by Point-of-care Testing, 2016-2026 (USD Million)
26. Global In-Vitro Cancer Diagnostics market by Patient Self-testing, 2016-2026 (USD Million)
27. Global In-Vitro Cancer Diagnostics market by Other End Users, 2016-2026 (USD Million)
28. Global In-Vitro Cancer Diagnostics market revenue share, by region, 2018 & 2025
29. North America In-Vitro Cancer Diagnostics market, 2016-2026 (USD Million)
30. Europe In-Vitro Cancer Diagnostics market, 2016-2026 (USD Million)
31. Asia Pacific In-Vitro Cancer Diagnostics market, 2016-2026 (USD Million)
32. Latin America In-Vitro Cancer Diagnostics market, 2016-2026 (USD Million)
33. Middle East & Africa In-Vitro Cancer Diagnostics market, 2016-2026 (USD Million)
Table Of Tables
List of Tables
1. Global In-Vitro Cancer Diagnostics market: snapshot
2. Drivers for In-Vitro Cancer Diagnostics market: impact analysis
3. Restraints for In-Vitro Cancer Diagnostics market: impact analysis
4. North America In-Vitro Cancer Diagnostics market revenue, by country, 2016-2026 (USD Million)
5. North America In-Vitro Cancer Diagnostics market revenue, by Product, 2016-2026 (USD Million)
6. North America In-Vitro Cancer Diagnostics market revenue, by Technology, 2016-2026 (USD Million)
7. North America In-Vitro Cancer Diagnostics market revenue, by Application, 2016-2026 (USD Million)
8. The U.S. In-Vitro Cancer Diagnostics market revenue, by Product, 2016-2026 (USD Million)
9. The U.S. In-Vitro Cancer Diagnostics market revenue, by Technology, 2016-2026 (USD Million)
10. The U.S. In-Vitro Cancer Diagnostics market revenue, by Application, 2016-2026 (USD Million)
11. Rest of North America In-Vitro Cancer Diagnostics market revenue, by Product, 2016-2026 (USD Million)
12. Rest of North America In-Vitro Cancer Diagnostics market revenue, by Technology, 2016-2026 (USD Million)
13. Rest of North America In-Vitro Cancer Diagnostics market revenue, by Application, 2016-2026 (USD Million)
14. Europe In-Vitro Cancer Diagnostics market revenue, by country, 2016-2026 (USD Million)
15. Europe In-Vitro Cancer Diagnostics market revenue, by Product, 2016-2026 (USD Million)
16. Europe In-Vitro Cancer Diagnostics market revenue, by Technology, 2016-2026 (USD Million)
17. Europe In-Vitro Cancer Diagnostics market revenue, by Application, 2016-2026 (USD Million)
18. U.K. In-Vitro Cancer Diagnostics market revenue, by Product, 2016-2026 (USD Million)
19. U.K. In-Vitro Cancer Diagnostics market revenue, by Technology, 2016-2026 (USD Million)
20. U.K. In-Vitro Cancer Diagnostics market revenue, by Application, 2016-2026 (USD Million)
21. France In-Vitro Cancer Diagnostics market revenue, by Product, 2016-2026 (USD Million)
22. France In-Vitro Cancer Diagnostics market revenue, by Technology, 2016-2026 (USD Million)
23. France In-Vitro Cancer Diagnostics market revenue, by Application, 2016-2026 (USD Million)
24. Germany In-Vitro Cancer Diagnostics market revenue, by Product, 2016-2026 (USD Million)
25. Germany In-Vitro Cancer Diagnostics market revenue, by Technology, 2016-2026 (USD Million)
26. Germany In-Vitro Cancer Diagnostics market revenue, by Application, 2016-2026 (USD Million)
27. Rest of Europe In-Vitro Cancer Diagnostics market revenue, by Product, 2016-2026 (USD Million)
28. Rest of Europe In-Vitro Cancer Diagnostics market revenue, by Technology, 2016-2026 (USD Million)
29. Rest of Europe In-Vitro Cancer Diagnostics market revenue, by Application, 2016-2026 (USD Million)
30. Asia Pacific In-Vitro Cancer Diagnostics market revenue, by country, 2016-2026 (USD Million)
31. Asia Pacific In-Vitro Cancer Diagnostics market revenue, by Product, 2016-2026 (USD Million)
32. Asia Pacific In-Vitro Cancer Diagnostics market revenue, by Technology, 2016-2026 (USD Million)
33. Asia Pacific In-Vitro Cancer Diagnostics market revenue, by Application, 2016-2026 (USD Million)
34. China In-Vitro Cancer Diagnostics market revenue, by Product, 2016-2026 (USD Million)
35. China In-Vitro Cancer Diagnostics market revenue, by Technology, 2016-2026 (USD Million)
36. China In-Vitro Cancer Diagnostics market revenue, by Application, 2016-2026 (USD Million)
37. Japan In-Vitro Cancer Diagnostics market revenue, by Product, 2016-2026 (USD Million)
38. Japan In-Vitro Cancer Diagnostics market revenue, by Technology, 2016-2026 (USD Million)
39. Japan In-Vitro Cancer Diagnostics market revenue, by Application, 2016-2026 (USD Million)
40. India In-Vitro Cancer Diagnostics market revenue, by Product, 2016-2026 (USD Million)
41. India In-Vitro Cancer Diagnostics market revenue, by Technology, 2016-2026 (USD Million)
42. India In-Vitro Cancer Diagnostics market revenue, by Application, 2016-2026 (USD Million)
43. Rest of Asia Pacific In-Vitro Cancer Diagnostics market revenue, by Product, 2016-2026 (USD Million)
44. Rest of Asia Pacific In-Vitro Cancer Diagnostics market revenue, by Technology, 2016-2026 (USD Million)
45. Rest of Asia Pacific In-Vitro Cancer Diagnostics market revenue, by Application, 2016-2026 (USD Million)
46. Latin America In-Vitro Cancer Diagnostics market revenue, by country, 2016-2026 (USD Million)
47. Latin America In-Vitro Cancer Diagnostics market revenue, by Product, 2016-2026 (USD Million)
48. Latin America In-Vitro Cancer Diagnostics market revenue, by Technology, 2016-2026 (USD Million)
49. Latin America In-Vitro Cancer Diagnostics market revenue, by Application, 2016-2026 (USD Million)
50. Brazil In-Vitro Cancer Diagnostics market revenue, by Product, 2016-2026 (USD Million)
51. Brazil In-Vitro Cancer Diagnostics market revenue, by Technology, 2016-2026 (USD Million)
52. Brazil In-Vitro Cancer Diagnostics market revenue, by Application, 2016-2026 (USD Million)
53. Rest of Latin America In-Vitro Cancer Diagnostics market revenue, by Product, 2016-2026 (USD Million)
54. Rest of Latin America In-Vitro Cancer Diagnostics market revenue, by Technology, 2016-2026 (USD Million)
55. Rest of Latin America In-Vitro Cancer Diagnostics market revenue, by Application, 2016-2026 (USD Million)
56. Middle East & Africa In-Vitro Cancer Diagnostics market revenue, by Product, 2016-2026 (USD Million)
57. Middle East & Africa In-Vitro Cancer Diagnostics market revenue, by Technology, 2016-2026 (USD Million)
58. Middle East & Africa In-Vitro Cancer Diagnostics market revenue, by Application, 2016-2026 (USD Million)
Methodology
FrequentlyAsked Questions
The global in vitro cancer diagnostics (IVD) market is expected to grow due to increasing demand for early cancer detection, rising cancer prevalence, advancements in diagnostic technologies, growing awareness about personalized medicine, and the expansion of healthcare infrastructure.
According to a study, the global in vitro cancer diagnostics (IVD) market size was worth around USD 77.07 Billion in 2024 and is expected to reach USD 144.96 Billion by 2034.
The global in vitro cancer diagnostics (IVD) market is expected to grow at a CAGR of 6.5% during the forecast period.
North America is expected to dominate the in vitro cancer diagnostics (IVD) market over the forecast period.
Leading players in the global in vitro cancer diagnostics (IVD) market include QIAGEN N.V., Ortho Clinical Diagnostics, DiaSorin, bioMérieux, Sysmex Corporation, Bio-Rad Laboratories, Becton, Dickinson and Company, Johnson & Johnson, Thermo Fisher Scientific, Danaher Corporation, Siemens Healthineers, and Roche Diagnostics, among others.
The report explores crucial aspects of the in vitro cancer diagnostics (IVD) market, including a detailed discussion of existing growth factors and restraints, while also examining future growth opportunities and challenges that impact the market.
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed